Skip Navigation
Menu
Original Research |1 December 1959

CHLOROQUINE PHOSPHATE (ARALEN) IN THE LONG-TERM TREATMENT OF RHEUMATOID ARTHRITIS1

J. PAUL YOUNG, M.D.

FULL TEXT

Abstract

This report describes the results obtained in a group of 50 consecutive private patients with chronic rheumatoid arthritis who received chloroquine phosphate (Aralen) as the major medical agent in the management of their disease for 18 to 36 months. The average duration of treatment was 24 months. An analysis of the successes and failures in this group will be presented with the clinical, laboratory and radiological changes that occurred during treatment. A dose schedule was evolved which was found to give the best results to the greatest number of patients with the least incidence of side effects.

During an intensive

FULL TEXT
PDF
Not Available
Citations
Citation

YOUNG JP. CHLOROQUINE PHOSPHATE (ARALEN) IN THE LONG-TERM TREATMENT OF RHEUMATOID ARTHRITIS1. Ann Intern Med. 1959;51:1159–1178. doi: 10.7326/0003-4819-51-6-1159

Download citation file:

© 2018

×
Permissions

Published: Ann Intern Med. 1959;51(6):1159-1178.

DOI: 10.7326/0003-4819-51-6-1159

12 Citations

Related Articles
Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis: A Nationwide Population-Based Cohort Study
Annals of Internal Medicine; ():
In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms
Annals of Internal Medicine; 168 (4): JC23
Erosive Rheumatoid Arthritis After Bilateral Hand Transplantation
Annals of Internal Medicine; 167 (3): 216-218
Patients with new-onset rheumatoid arthritis had increased risk for ischemic and nonischemic heart failure
Annals of Internal Medicine; 167 (2): JC8
View MoreView Less

Journal Club
In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms
Annals of Internal Medicine; 168 (4): JC23
Patients with new-onset rheumatoid arthritis had increased risk for ischemic and nonischemic heart failure
Annals of Internal Medicine; 167 (2): JC8
Review: In rheumatoid arthritis, TNF-α inhibitors do not differ from placebo or DMARDs for all-cause mortality
Annals of Internal Medicine; 164 (4): JC20
Review: In rheumatoid arthritis, adding rituximab to methotrexate improves clinical outcomes
Annals of Internal Medicine; 162 (12): JC9
View MoreView Less

Related Point of Care
Rheumatoid Arthritis
Annals of Internal Medicine; 153 (1): ITC1-1
View MoreView Less

Related Topics
Geriatric Medicine
Rheumatoid Arthritis
Rheumatology

Geriatric Medicine, Rheumatoid Arthritis, Rheumatology.

PubMed Articles
Noradrenaline modifies arterial reflection phenomena and left ventricular efficiency in septic shock patients: A prospective observational study.
J Crit Care 2018;
Particulate matter air pollution components and incidence of cancers of the stomach and the upper aerodigestive tract in the European Study of Cohorts of Air Pollution Effects (ESCAPE).
Environ Int 2018;
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2018 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×